Useful links
Unit of study_
PHAR3819: Gastrointestinal
2024 unit information
This unit of study will cover the therapeutics of gastrointestinal and hepatic disorders including the pharmaceutical sciences that underpin such drug therapies. This unit will also include the epidemiology, pathophysiology and clinical features of gastrointestinal and hepatic disorders. Through the use of case-based learning, students will participate in the interpretation, application and dissemination of pharmaceutical and pharmacotherapeutic concepts and knowledge. On completion of this unit of study students will be able to apply an understanding of the pharmaceutical sciences to optimising the drug and non-drug therapy of patients with gastrointestinal and hepatic disorders. Interprofessional communication and the application of specialist knowledge to implementing pharmacist cognitive services such as clinical interventions and/or medication management review will also be explored. Students will become familiar with drug information software and a number of computerised drug information. Role-plays will be used to develop students' communication skills for interaction between pharmacists and their clients (patients, doctors, other health professionals).
Unit details and rules
Managing faculty or University school:
Pharmacy
| Code | PHAR3819 |
|---|---|
| Academic unit | Pharmacy |
| Credit points | 5 |
|
Prerequisites:
?
|
(BIOL1XX8 or BIOL1XX3) and (CHEM1611 or CHEM11X2 or CHEM19X2 or CHEM1904) and (CHEM1612 or CHEM11X1 or CHEM19X1 or CHEM1903) and (BIOL1XX7 or MBLG1XX1) and PHAR1811 and PHAR1812 and PHAR1821 and PHAR1822 and PCOL2605 and PHAR2811 and PHAR2812 and PHAR2813 and PHAR2821 and PHAR2822 and PHAR2823 and PHSI2601 |
|---|---|
|
Corequisites:
?
|
PHAR3815 and PHAR3816 and PHAR3817 and PHAR3818 |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
None |
At the completion of this unit, you should be able to:
- LO1. Demonstrate an understanding of the epidemiology and pathophysiology associated with gastrointestinal disorders
- LO2. Identify the most appropriate evidence-based treatments and the appropriate advice and counselling to patients with gastrointestinal disorders.
- LO3. Demonstrate an understanding of the chemistry and pharmacology that forms the basis of structure-activity relationships, drug-drug interactions and drug design of medicines used for gastrointestinal disorders
- LO4. Identify and manage medication-related adverse events and provide appropriate advice/counselling to health care professionals (HCPs) or patients with gastrointestinal disorders
- LO5. Communicate effectively and ethically with patients, their families and HCPs about the optimal management of gastrointestinal disorders
- LO6. Identify and utilise appropriate resources that are used to form the basis for decisions on which medicines and services are recommended to patients and other HCPs.
- LO7. Critically examine scientific evidence, both quantitative and qualitative, in order to arrive at evidence-based conclusions.
- LO8. Work effectively and cooperatively as a member of a learning team.
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
